An approach to the mechanism of action of antibiotics is to ascertain metabolites which are involved directly in the inhibition of the bacterial cell by a specific antibiotic. A simple means of testing involvement of metabolites in antibiotic inhibition derives from the demonstration (Foster and Pittillo, 1953) that complex natural materials, in small amounts, permit growth in otherwise inhibitory concentrations of penicillin, dihydrostreptomycin, aureomycin, chloramphenicol, or teriamycin. Reversal of inhibition caused by certain antibiotics has been reported for specific metabolites, e.g., actathiazic acid by biotin or pimelic acid (Grundy et al., 1952) , erythromycin by pantothenic acid, g-alanine or l-carnosine (Brown and Emerson, 1953) , chloramphenicol by phenylalanine, tyrosine, tryptophan, or glycine (Woolley, 1950; Mentzer et al., 1950) , and streptomycin by pantothenic acid (Lichstein and Gilfillan, 1951) . However, in most cases the experiments were conducted in liquid media with relatively heavy inocula, and, from the data presented, proof of reversal is not unequivocal owing to lack of information as to sensitivity of cells in the "reversed" cultures. Theoretical aspects of reversal relative to procedures, with particular emphasis on selection of resistors by complex supplements in liquid media, have been covered in our previous paper (Foster and Pittillo, 1953).
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The present paper describes experiments on each of the first mentioned five antibiotics listed above in which reversal was tested with various metabolites. The degree of reversal obtained ranged from slight to very marked; even in the case of the latter there was a limit to the reversibility. Deducible from these results is that disturbance of the metabolism of the metabolite I Supported by a grant from the WilliamsWaterman Fund for the Combat of Dietary Diseases, and in part by a grant-in-aid from the American Cancer Society upon recommendation of the Committee on Growth of the National Research Council.
is at least part of the effect caused by an antibiotic when it inhibits the growth of a susceptible organism.
MATERIALS AND METHODS
The spread plate procedure using 1\1-9 agar (Anderson, 1946) and Escherichia coli, strain B, has been employed exactly as described previously (Foster and Pittillo, 1953) ; repetition of the details is unnecessary. Briefly, the method involves preparation of replicate series of M-9 agar petri plates containing graded doses of an antibiotic, differing by a factor of two. Some of the series received specified concentrations of metabolites; others, none. The concentration of antibiotic required for complete inhibition in the presence of the metabolite, compared to that in the absence, is called "reversal factor". Recovery of fewer colonies than on control plates is regarded as "partial reversal". The inoculum consisted of 50 to 150 twice-washed bacterial cells spread over the entire surface of the agar, and colony counts generally were made after 36 hours at 37 C.
The antibiotics and the metabolites were dissolved in sterile distilled water and added without further sterilization to cooled melted sterilized MI-9 agar in sterile petri plates and the whole thoroughly mixed. Appearance of a colony, however small as compared to control colonies, was regarded as evidence of failure of the antibiotic to inhibit. Mixtures displaying a reversal factor generally greater than 2 were resolved and individual components tested for reversing power at the same concent-ation5 as they were present in the mixture.
RESULTS OF SCREENING SURVEY
A brief summary will be given of the over-all screening tests for reversal of the individual antibiotics.
Aureomycin. (a) Amino acids. Glycine gave a 4-fold reversal. Aureomycin (e) Basamine. One mg per ml resulted in a 4-fold reversal factor.
Aureomycin was the only antibiotic of the 5 tested in which reversal by metabolites was striking (see below). However, penicillin G, dihydrostreptomycin, chloramphenicol, and terramycin were definitely reversible over a small concentration range by specific metabolites. That basamine always showed a higher reversal than any individual compound may indicate that the reversing activity of the latter was due to untested known or unknown components or to the known reversing components in combination.
AUREOMYCIN REVERSAL
Reversal separately by vitamins, by ribosides, and by glycine. Tables 1 and 2 illustrate the data from experiments in which individual vitamins, individual ribosides, and glycine were shown to reverse otherwise inhibitory concentrations of aureomycin. In table 1, 1.0 ,ug aureomycin sufficed for complete inhibition in the absence of added vitamins, whereas in the presence of the larger concentration of the vitamin supplements the level of aureomycin required for complete inhibition was considerably higher. Riboflavin was outstanding in this respect. In its presence (2 Mug) even 8 MAg of aureomycin were incapable of causing any inhibition. Biotin, thiamin, pyridoxine, and pyridoxamine each increased 8-fold the aureomycin level required for inhibition; p-aminobenzoic acid, folic acid, and calcium pantothenate increased it 4-fold; vitamin B12, slightly; and nicotinic acid, none.
Each of the ribosides tested had some reversing activity (table 2), inosine being superior in this respect with an 8-fold reversing factor. Inosine proved to be less effective a reversing agent than riboflavin, less than 1 Mug of the latter causing a degree of reversal obtainable only with a considerably larger amount of inosine.
Glycine also was a less effective reversing agent than riboflavin (table 2), a reversal factor of 8 being obtained with 80 ,ug of the amino acid. The reversing power of glycine increased with concentration, suggesting a competitive relation.
The proportion between aureomycin level and concentration of riboflavin required for reversal is clear-cut (table 2) , also suggesting a competitive relation. The highest level of riboflavin tested, 2.0 ,g, was somewhat toxic by itself.
Terramycin can be distinguished readily from aureomycin because under the conditions described here inhibition of E. coli, strain B, by terramycin was completely irreversible by riboflavin.
There appears to be no chemical interaction between riboflavin and aureomycin, one inactivating the other. Equal parts of these two compounds in microgram quantities per ml were allowed to stand 4 hours, autoclaved to destroy the aureomycin, and the riboflavin content assayed with Lactobacillus casei (BartonWright, 1952) . There was no loss in riboflavin activity as compared to a control.
Reversal by combinations of metabolites. Table  3 indicates that riboflavin and glycine act synergistically in reversal of an otherwise inhibitory concentration of aureomycin. In other experiments the same thing has been found for the combinations riboflavin-inosine and glycineinosine. Evident in table 3 is that 60 Mg glycine alone had a reversal power allowing 22 out of a possible 82 colonies to develop, and that 0.5 MAg riboflavin alone allowed 38 to develop. However, these two supplements combined gave complete recovery of all the colonies (87).
Similarly, in another experiment, 0.5 ,g inosine alone reversed the inhibition of 21 of a possible 56 colonies, and 0.6 Mug riboflavin alone reversed the inhibition of only 8 colonies. Combined, the activity of the two supplements was more than additive, reversing the inhibition of 46 colonies.
Colony recovery with 0.7 MAg riboflavin alone was submaximal; in combination with 0.5 MAg inosine the vitamin gave maximal colony recovery.
Also, in a third experiment, 0.5 ug inosine alone recovered 18 of a possible 56 colonies, and 70 MAg glycine alone recovered 37. These concentrations combined resulted in maximal recovery. Interpretation of these synergism experiments is made in the discussion.
Reversal of aureomycin inhibition of other bacteria. Twelve different organisms which grew well in M-9 medium and which were sensitive to (Foster and Heiligman, 1949) .
Riboflavin was uniformly the most potent reversing compound. In the case of Serratia marcescens, glycine was almost as potent as riboflavin, whereas for BaciUus globigii neither glycine nor inosine showed significant reversal of aureomycin inhibition. Similarly, inosine was half as active as riboflavin and glycine in reversing inhibition of BaciUus megaterium but was considerably less active than those metabolites in Aerobacter aerogenes and S. marcescene; it had no significant activity in reversing the inhibition of B. globigii cells. 0.25 pg aureomycin per ml, 41, 67 = 54 avg 0.50 ug aureomycin per ml, 0, 11 = 6 avg 1.0 ,g aureomycin per ml, 0, 0 = 0 avg 2.0 ,ug aureomycin per ml, 0, 0 = 0 avg. 7.4 being demonstrably more conducive to reversal than pH 7.0 or less or pH 7.6 or above.
Reversal by riboflavin analogues. Galactoflavin, lyxoflavin, and sorbitylisoalloxazine were supplied generously by Drs (Foster, 1944) . Aureomycin was found to be without effect on the oxidation of riboflavin by washed cellular suspensions of this organism. The oxidation was followed by fluorimetric determination of residual riboflavin.
PROTECTED INHIBITION
The foregoing results, especially those demonstrating a competitive inhibition of utilization of one or more metabolites by aureomycin, imply that however effective aureomycin may be as an inhibitor of growth its intrinsic effectiveness must be masked by those metabolites present in the test bacterial cell. Whether of exogenous or endogenous origin, presumably they are present intracellularly in finite amounts, and it is reasonable to assume that to some unpredictable degree they antagonize a concentration of aureomycin which otherwise would be inhibitory. Where the reversing metabolites are of endogenous origin, as in these experiments, it follows that inhibition by aureomycin will occur only at a concentration sufficient to overcome the reversing potential of the intracellular metabolites, particularly riboflavin. Expected therefore would be an apparent potentiation of aureomycin activity, i.e., inhibition by a lower level than otherwise required, if the concentration of the specific metabolites is reduced. One way to achieve this would be to inhibit the synthesis of excess metabolite by the cell. It is possible to test this idea in the case of riboflavin synthesis. Woolley (1950) has shown that 1,2-dichloro4,5-diaminobenzene inhibits riboflavin synthesis in B. megaterium and that the inhibition was reversed by 1,2-dimethyl-4, 5-diaminobenzene. He interpreted these results as meaning that 1,2-dimethyl44,5-diaminobenzene or a compound closely related to it is a normal precursor in the biosynthesis of riboflavin, and that the analogue 1 ,2-dichloro4,5-diaminobenzene is a competitive inhibitor of the utilization of 1 ,2-dimethyl4,5-diaminobenzene. It re-1953] mained to test whether the analogue can be used to effectively lower the riboflavin concentration in the cell, and by so doing "protect" the intrinsic inhibitory action of aureomycin. 1,2-Dichloro-4,5-diaminobenzene was kindly furnished by Dr. Karl Pfister of Merck & Co., Inc.
B. subtilis, strain ATCC 6633, was found to be inhibited by 1 ,2-dichloro4,5-diaminobenzene, presumably in part at least, by interference with its riboflavin synthesis. Riboflavin reverses aureomycin inhibition of this organism to a marked extent (see above). Cross concentration experiments using 1 ,2-dichloro4,5-diaminobenzene and aureomycin to inhibit this organism showed (table 5) that by itself 0.125 jig aureomycin per ml was required for complete inhibition, and by itself, 12.0 ,ug 1,2-dichloro4,5-diaminobenzene. Six mg 1,2-dichloro4,5-diam- When combined with 6 jig 1,2-dichloro44,5-diaminobenzene, 0.0075 Mg aureomycin was completely inhibitory. Thus, a noninhibitory concentration of 1,2-dichloro4,5-diaminobenzene has apparently potentiated aureomycin activity 16- fold. In all probability, however, 1,2-dichloro-4,5-diaminobenzene has protected the aureomycin from reversal by riboflavin by inhibiting synthesis of the latter. The term "protected inhibition" is proposed to describe this phenomenon. In a second experiment the apparent potentiation of aureomycin was 8-fold. Inhibition of riboflavin synthesis by 1,2-dichloro-4 ,6-diaminobenene. B. #ubtilis, strain ATCC 6633, was cultivated in the presence of graded doses of 1,2-dichloro44,5-diaminobenzene for 22 hours in M-9 broth on a shaking machine. Inhibition of growth was definite, but not complete, in the flasks containing 200 and 400 ,g 1,2-dichloro44,5-diaminobenzene per ml, respectively. Aliquots were removed for dry weight determinations of the cells present in each flask, after washing by centrifugation. Other portions of the whole cultures were acidified with acetic acid and autoclaved to release bound riboflavin. After neutralization the riboflavin content of the clear supernatant was determined by means of the L. casei assay (Barton-Wright, 1952 It is probable that the reversing metabolites, especially those active at very low levels, represent the most sensitive sites of inhibition in cells growing under these conditions. That several metabolites can reverse an antibiotic may be taken as further evidence, already implicit in enzyme studies (Smith, 1953) inhibition of other mechanisms at threshold inhibitory levels of the antibiotic. In the case of aureomycin, at the levels employed, the riboflavin metabolism apparently was inhibited selectively since the vitamin alone can reverse the inhibition.
The concept of protected inhibition is similar to the synergistic experiments of Beerstecher and Shive (1947) and the sequential blocking of Potter (1951) , but is distinct in the implication that one finds empirically by a method such as we have described a reversing metabolite for any inhibitor, then combines with the inhibitor in a bacterial culture a compound inhibiting the synthesis of that metabolite. Also implied here is that one automatically selects perhaps the most susceptible mechanisms in the cell to any given concentration of inhibitor. The 1953] level of dichlorodiaminobenzene only one-sixteenth the amount of aureomycin was required to inhibit B. subtilis, strain ATCC 6633, than was required in the absence of the analogue. The concept of protected inhibition is developed and proposed as the mechanism of the observed potentiation. The generalized significance of protected inhibition as a rationale arid tool for new drug therapy is discussed.
